BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22020669)

  • 1. Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation.
    Dieckmann A; Kriebel M; Andriambeloson E; Ziegler D; Elmlinger M
    Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):132-8. PubMed ID: 22020669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy.
    Sharma SS; Kumar A; Kaundal RK
    Life Sci; 2008 Mar; 82(11-12):570-6. PubMed ID: 18262571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
    Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
    J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
    Negi G; Kumar A; Sharma SS
    Biochem Biophys Res Commun; 2010 Jan; 391(1):102-6. PubMed ID: 19900402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
    Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
    Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
    Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
    Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc supplementation alleviates diabetic peripheral neuropathy by inhibiting oxidative stress and upregulating metallothionein in peripheral nerves of diabetic rats.
    Liu F; Ma F; Kong G; Wu K; Deng Z; Wang H
    Biol Trace Elem Res; 2014 May; 158(2):211-8. PubMed ID: 24615552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy.
    Negi G; Kumar A; Kaundal RK; Gulati A; Sharma SS
    Neuropharmacology; 2010 Mar; 58(3):585-92. PubMed ID: 20005237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance occurs in parallel with sensory neuropathy in streptozotocin-induced diabetes in rats: differential response to early vs late insulin supplementation.
    Szilvássy Z; Németh J; Kovács P; Paragh G; Sári R; Vígh L; Peitl B
    Metabolism; 2012 Jun; 61(6):776-86. PubMed ID: 22154324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic neuropathy: electrophysiological and morphological study of peripheral nerve degeneration and regeneration in transgenic mice that express IFNbeta in beta cells.
    Serafín A; Molín J; Márquez M; Blasco E; Vidal E; Foradada L; Añor S; Rabanal RM; Fondevila D; Bosch F; Pumarola M
    Muscle Nerve; 2010 May; 41(5):630-41. PubMed ID: 19918773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats.
    Shimoshige Y; Minoura K; Matsuoka N; Takakura S; Mutoh S; Kamijo M
    Brain Res; 2009 Jan; 1247():182-7. PubMed ID: 18992730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
    Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy.
    Li F; Drel VR; Szabó C; Stevens MJ; Obrosova IG
    Diabetes; 2005 May; 54(5):1514-22. PubMed ID: 15855340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.
    Obrosova IG; Xu W; Lyzogubov VV; Ilnytska O; Mashtalir N; Vareniuk I; Pavlov IA; Zhang J; Slusher B; Drel VR
    Free Radic Biol Med; 2008 Mar; 44(6):972-81. PubMed ID: 17976390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
    Liu Y; Wang L; Li X; Lv C; Feng D; Luo Z
    Biochem Biophys Res Commun; 2010 Aug; 399(1):49-54. PubMed ID: 20637731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallotannin ameliorates the development of streptozotocin-induced diabetic nephropathy by preventing the activation of PARP.
    Chandak PG; Gaikwad AB; Tikoo K
    Phytother Res; 2009 Jan; 23(1):72-7. PubMed ID: 18693296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-allodynic and neuroprotective effects of koumine, a Benth alkaloid, in a rat model of diabetic neuropathy.
    Ling Q; Liu M; Wu MX; Xu Y; Yang J; Huang HH; Yu CX
    Biol Pharm Bull; 2014; 37(5):858-64. PubMed ID: 24790009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
    Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
    Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.
    Ilnytska O; Lyzogubov VV; Stevens MJ; Drel VR; Mashtalir N; Pacher P; Yorek MA; Obrosova IG
    Diabetes; 2006 Jun; 55(6):1686-94. PubMed ID: 16731831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.